Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N07CA01	BETAHISTINE ARROW	G	Betahistine dihydrochloride - 16mg	16mg	Tablet	362,837 L.L
A10BB12	JOSWE GLEMAX 4	G	Glimepiride - 4mg	4mg	Caplet	593,978 L.L
B01AB12	HIBOR	G	Bemiparin Sodium - 7,500IU	7,500IU	Injectable solution	2,198,526 L.L
B05BB02	DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	180,421 L.L
C08CA01	AMLORINE 10	G	Amlodipine (besylate) - 10mg	10mg	Tablet	959,504 L.L
C09DX	LOSANET AM PLUS	G	Losartan potassium - 100mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg		Tablet	1,044,358 L.L
J01DE01	SALAPIME	G	Cefepime - 1g	1g	Injectable powder for solution	618,168 L.L
L01XG01	ALVOCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	14,169,600 L.L
M05BA04	OREK	G	Alendronate - 70mg	70mg	Tablet, coated	2,404,838 L.L
N03AG01	CONVULEX	G	Sodium Valproate - 300mg/ml	300mg/ml	Solution	1,018,633 L.L
N05AX08	RISCHOTIC OD 3	G	Risperidone - 3mg	3mg	Tablet, orally disintegrating	605,369 L.L
N07CA01	VASOSERC FORTE	G	Betahistine dihydrochloride - 16mg	16mg	Tablet	944,529 L.L
R05CB01	TREBON N	G	Acetylcysteine - 600mg	600mg	Granules for suspension	596,666 L.L
A04AA01	APO-ONDANSETRON	G	Ondansetron - 8mg	8mg	Tablet	1,491,665 L.L
A10BB12	ORBIDE	G	Glimepiride - 4mg	4mg	Tablet	357,078 L.L
B05BB02	DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	186,167 L.L
C08CA01	TORANS	G	Amlodipine (besylate) - 10mg	10mg	Tablet	716,716 L.L
D04AB01	AVOCAINE	G	Lidocaine - 10%	10%	Spray	400,465 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	11,020,381 L.L
L04AX04	LEDOBOOK 25	G	Lenalidomide - 25mg	25mg	Capsule	67,887,540 L.L
M05BA04	OSTEOMED	G	Alendronic acid (sodium alendronate) - 70mg	70mg	Tablet, scored	950,929 L.L
N05AX08	RISCHOTIC OD 4	G	Risperidone - 4mg	4mg	Tablet, orally disintegrating	605,369 L.L
N07CA01	VERTINEX	G	Betahistine dihydrochloride - 16mg	16mg	Tablet, scored	1,204,339 L.L
S01XA18	DRYFREE	G	Ciclosporin - 0.05%	0.05%	Drops	2,257,655 L.L
A04AA01	NAUSETRON	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, scored	1,023,880 L.L
A10BB12	JOSWE GLEMAX 6	G	Glimepiride - 6mg	6mg	Caplet	663,858 L.L
B05BB02	MIXTE SIMPLE (2)	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	182,720 L.L
C08CA04	NICARDIPINE ARROW	G	Nicardipine chlorhydrate - 10mg/10ml	10mg/10ml	Injectable solution	2,590,928 L.L
C09DX01	VIOSTAN AM PLUS 160/5/25	G	Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 25mg		Tablet, film coated	1,196,020 L.L
D04AB01	PROCOMIL	G	Lidocaine - 10%	10%	Spray	139,760 L.L